BXPHF

BOTANIX PHARMACEUTICALS by Botanix Pharmaceuticals Ltd. (BXPHF)

About BOTANIX PHARMACEUTICALS by Botanix Pharmaceuticals Ltd. (BXPHF)

Botanix Pharmaceuticals Ltd. is a dermatology company, which engages in the provision of business of researching and developing dermatology and antimicrobial products. It operates through the Australia and the United States geographical segments. The company was founded by Matthew Callahan, Roger New, and Glen Travers in 1984 and is headquartered in West Perth, Australia.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.50
52 Week Low
$0.01
Market cap
421.5M
Dividend yield
0.00%
Volume
--
Avg. volume
3,658
P/E ratio
-16.08

BOTANIX PHARMACEUTICALS by Botanix Pharmaceuticals Ltd. News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.50
52 Week Low
$0.01
Market cap
421.5M
Dividend yield
0.00%
Volume
--
Avg. volume
3,658
P/E ratio
-16.08